NEW YORK, April 2 – Affymetrix subsidiary Perlegen Sciences said Monday it had raised $100 million in financing from a group of institutional and individual investors.

Following the private placement, Affymetrix will own 52 percent of Perlegen, a company launched in October to apply Affymetrix’s GeneChip technology to the entire human genome.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.